Health - Google News: US delays decision on Takeda diabetes drug - Reuters

Health - Google News Google News

US delays decision on Takeda diabetes drug - Reuters Apr 26th 2012, 03:46 US delays decision on Takeda diabetes drug Reuters (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said US regulators had extended their review of its diabetes drug alogliptin, requesting additional data on what the company hopes will be the successor to its top-selling Actos drug. Takeda's Successor Drug to Actos Fails to Win ApprovalBloomberg Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes ...PR Newswire (press release) FDA rejects diabetes drug alogliptin; Takeda gives few CRL detailsMedCity News DrugWatch.com -InjuryBoard.com all 19 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: